Skip to main content

and
  1. Article

    Open Access

    Treatment outcomes of patients with multidrug and extensively drug-resistant tuberculosis in Zhejiang, China

    The aim of this study was to assess the treatment outcomes of multidrug and extensively drug-resistant tuberculosis (M/XDR-TB) in Zhejiang, China and to evaluate possible risk factors associated with poor outc...

    Ming-Wu Zhang, Lin Zhou, Yu Zhang, Bin Chen in European Journal of Medical Research (2021)

  2. Article

    Open Access

    A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Tong Luo Hua Shi capsule, a modernized Tibetan medicine, in patients with rheumatoid arthritis

    Tong Luo Hua Shi (TLHS) is a new formulation of the traditional Tibetan medicine Wu-wei-gan-lu that has been used for the treatment of rheumatoid arthritis (RA) for hundreds of years in China. This study aimed...

    Wei Liu, Yuan-Hao Wu, Si-Yuan Hu, Cheng-Liang Zhong, Ming-Li Gao, Dong-Wu Liu in Trials (2016)

  3. Article

    Open Access

    Risk factors for post-ERCP pancreatitis: a systematic review of clinical trials with a large sample size in the past 10 years

    Post- endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is the most common and most severe complication associated with diagnostic and therapeutic ERCP. A multivariate analysis of risk f...

    Jian-Jun Chen, **-Mo Wang, **ng-Qiang Liu, Wen Li in European Journal of Medical Research (2014)